Answers are grounded in this paper and cite their sources.
Acute kidney injury (AKI) has been well described as a complication of immune checkpoint inhibitor therapy. We present a series of patients, the majority with lung adenocarcinoma, who developed AKI while actively receiving immune checkpoint inhibitors.
No takes yet. Share an insight, caveat, or question.
Muddasani et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: